Updated On: 17 September, 2022 05:52 PM IST | Mumbai | mid-day online correspondent
FDA Assistant Commissioner Ganesh Rokade said, we had collected two samples from Nagpur and Pune between 2022-21. During our quality check process, the samples were not found to be of standard quality

File Pic
The Food and Drugs Administration (FDA), Maharashtra said that it has taken action against Johnson’s Baby Powder. An official statement released by the FDA Maharashtra said that it has cancelled the product manufacturing licence of Johnson’s Baby Powder.
FDA Assistant Commissioner Ganesh Rokade said, "We had collected two samples from Nagpur and Pune between 2022-21. During our quality check process, the samples were not found to be of standard quality. The firm did not accept the report and had challenged the testing analysis in court for sending to the referral laboratory i.e Central Drugs Laboratory Govt., of India, Kolkata. The Director CDL, Kolkata confirms the report of Govt., Analyst, FDA Maharashtra and issued a final conclusive report stating the conclusion that 'The sample does not comply to IS5339: 2004 with respect to the test for pH'. As a result, we have issued instructions to recall the stock of the said product from the market."